Nalbuphine Hydrochloride Market Is Likely to Experience a Tremendous Growth by 2029
Nalbuphine hydrochloride market is anticipated to grow at a significant CAGR during the forecast period. Nalbuphine HCL (Nalbuphine hydrochloride) or commonly known as nubain, belongs to a group of opioid analgesics, is a narcotic pain reliever used to treat moderate to severe pain as well as treats opioid addiction. Adding to this, nubain is also used in treatment of pain just after childbirth or surgery. Thus, the growing application of the drug is anticipated to provide a boost to the market growth. Another major factor likely to propel the market growth includes the widespread regulatory approval and efficacy, with considerably less capacity for euphoria or any respiratory depression in comparison to other opioids. This attribute of the drug has made it convenient for the drug suppliers and manufacturers to commercialize it under various company brand names including Mexifen, Nalbuphine, Nalpain, Kinz, Nalufin, Raltrox, Rubuphine, Nalbin, Analin, and Exnal, among others.
The global nalbuphine
hydrochloride market is segmented based on type and application. On the basis
of type, the market is sub segmented into adult and children. Among both these
types, the adult segment is likely to show a prominent growth owing to a
comparatively higher demand. Since the medicine is a composition of narcotic
pain reliever, it is only recommended to children in exclusively severe medical
conditions. Whereas on the basis of application, the market is further
segmented into hospital, pharmacy, and others. Among all of these, the pharmacy
sub segment is anticipated to hold a substantial market share, owing to the
significant demand for the drug attributed to its widespread regulatory
approval and efficacy.
To Request a Sample of our Report on Nalbuphine
Hydrochloride Market: https://www.omrglobal.com/request-sample/nalbuphine-hydrochloride-market
Market Coverage
• The market number available for – 2021-2029
• Base year- 2021
• Forecast period- 2023-2029
Segment Covered-
·
By Type
·
By Application
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape:
Glenmark Pharmaceuticals Ltd., Pfizer Inc., and Abbott Laboratories, among
others.
Nalbuphine Hydrochloride Market Report by Segment
By Type
•
Adult
•
Children
By Application
•
Hospital
•
Pharmacy
•
Others
A
full Report of Nalbuphine Hydrochloride Market is Available @ https://www.omrglobal.com/industry-reports/nalbuphine-hydrochloride-market
Nalbuphine
Hydrochloride Market by Region
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
•
Latin America
•
Middle East and Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/nalbuphine-hydrochloride-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment